| Nome |
# |
|
Erectile dysfunction and diabetes. A melting pot of circumstances and treatments, file e383532d-192a-15e8-e053-a505fe0a3de9
|
848
|
|
Diabetes and pancreatic neuroendocrine tumours: which interplays, if any?, file e3835322-3323-15e8-e053-a505fe0a3de9
|
656
|
|
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues, file e3835321-f3c7-15e8-e053-a505fe0a3de9
|
641
|
|
The management of neuroendocrine tumours: a nutritional viewpoint, file e3835322-82e8-15e8-e053-a505fe0a3de9
|
525
|
|
GLP-1: benefits beyond pancreas, file e3835322-4ebb-15e8-e053-a505fe0a3de9
|
520
|
|
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?, file e3835322-3466-15e8-e053-a505fe0a3de9
|
380
|
|
Epidemiology of gastroenteropancreatic neuroendocrine tumours., file e3835322-4bbf-15e8-e053-a505fe0a3de9
|
374
|
|
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors, file e3835322-9194-15e8-e053-a505fe0a3de9
|
347
|
|
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1), file e3835322-4bc9-15e8-e053-a505fe0a3de9
|
310
|
|
Ruolo diagnostico, prognostico e predittivo di risposta del NETest nelle neoplasie neuroendocrine, file e3835328-d3ac-15e8-e053-a505fe0a3de9
|
306
|
|
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group, file e3835323-5581-15e8-e053-a505fe0a3de9
|
305
|
|
Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study, file e3835323-a110-15e8-e053-a505fe0a3de9
|
305
|
|
Epigenetics in medullary thyroid cancer: from pathogenesis to targeted therapy, file e3835322-4bbd-15e8-e053-a505fe0a3de9
|
302
|
|
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database, file e3835322-346e-15e8-e053-a505fe0a3de9
|
292
|
|
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study, file e3835322-38fc-15e8-e053-a505fe0a3de9
|
292
|
|
Bone metabolism, bone mass and structural integrity profile in professional male football players, file e3835326-876c-15e8-e053-a505fe0a3de9
|
288
|
|
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study, file e3835322-4bc6-15e8-e053-a505fe0a3de9
|
281
|
|
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors, file e3835321-69ca-15e8-e053-a505fe0a3de9
|
280
|
|
The safety of available treatments options for neuroendocrine tumors, file e3835322-38f6-15e8-e053-a505fe0a3de9
|
277
|
|
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database, file e3835322-3473-15e8-e053-a505fe0a3de9
|
252
|
|
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives, file e3835322-4ebc-15e8-e053-a505fe0a3de9
|
252
|
|
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study, file e3835322-4a1b-15e8-e053-a505fe0a3de9
|
243
|
|
The evolving field of kinase inhibitors in thyroid cancer, file e3835322-4bcb-15e8-e053-a505fe0a3de9
|
237
|
|
Incidence of gastroenteropancreatic neuroendocrine tumours. A systematic review of the literature, file e3835326-bd70-15e8-e053-a505fe0a3de9
|
236
|
|
Natural history of localized and locally advanced lung atypical carcinoid after complete resection: a joined french-italian multicentric retrospective study, file e3835322-48d3-15e8-e053-a505fe0a3de9
|
220
|
|
Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience, file e3835322-9197-15e8-e053-a505fe0a3de9
|
220
|
|
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib, file e3835322-390c-15e8-e053-a505fe0a3de9
|
211
|
|
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients, file e3835322-d391-15e8-e053-a505fe0a3de9
|
203
|
|
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma, file e3835322-3479-15e8-e053-a505fe0a3de9
|
198
|
|
Functional characterization of human thyroid tissue with immunohistochemistry, file e3835321-e8df-15e8-e053-a505fe0a3de9
|
183
|
|
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy, file e3835322-347f-15e8-e053-a505fe0a3de9
|
183
|
|
Unintentional recurrent laryngeal nerve injuries following thyroidectomy. Is it the surgeon who pays the bill?, file e3835323-fb82-15e8-e053-a505fe0a3de9
|
176
|
|
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy, file e3835320-0c53-15e8-e053-a505fe0a3de9
|
154
|
|
Effects of diet and antihyperglycemic drugs on erectile dysfunction. A systematic review, file e383532e-f283-15e8-e053-a505fe0a3de9
|
151
|
|
Open issues on G3 neuroendocrine neoplasms: back to the future, file e3835322-390f-15e8-e053-a505fe0a3de9
|
150
|
|
Application of molecular biology of differentiated thyroid cancer for clinical prognostication, file e3835322-37bf-15e8-e053-a505fe0a3de9
|
146
|
|
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms, file e3835321-a546-15e8-e053-a505fe0a3de9
|
132
|
|
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery, file e3835323-d940-15e8-e053-a505fe0a3de9
|
121
|
|
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study, file e3835322-3468-15e8-e053-a505fe0a3de9
|
114
|
|
Animal models of medullary thyroid cancer: state of the art and view to the future, file e3835322-37c4-15e8-e053-a505fe0a3de9
|
113
|
|
Efficacy and safety of everolimus in extrapancreatic neuroendocrine tumor: a comprehensive review of literature, file e3835321-c5dc-15e8-e053-a505fe0a3de9
|
106
|
|
Correction to. Multiple endocrine neoplasia type 1. analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database, file e383532e-c125-15e8-e053-a505fe0a3de9
|
97
|
|
Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the "SERENA study", a randomized, double-blind, placebo-controlled trial, file e3835322-4948-15e8-e053-a505fe0a3de9
|
95
|
|
Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life, file e3835322-4bc2-15e8-e053-a505fe0a3de9
|
94
|
|
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study, file e383531b-bc28-15e8-e053-a505fe0a3de9
|
91
|
|
Canine insulinoma as a model for human malignant insulinoma research. Novel perspectives for translational clinical studies, file e383532e-8abc-15e8-e053-a505fe0a3de9
|
91
|
|
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal, file e3835322-cd5f-15e8-e053-a505fe0a3de9
|
89
|
|
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma, file e3835322-37c9-15e8-e053-a505fe0a3de9
|
88
|
|
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours, file e3835322-3625-15e8-e053-a505fe0a3de9
|
84
|
|
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study, file e3835322-3908-15e8-e053-a505fe0a3de9
|
84
|
|
Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness, file e3835323-a10f-15e8-e053-a505fe0a3de9
|
84
|
|
Circulating tumor cells and miRNAs as prognostic markers in neuroendocrine neoplasms, file e3835321-aaef-15e8-e053-a505fe0a3de9
|
82
|
|
Case Report. Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers, file e383532c-4bd5-15e8-e053-a505fe0a3de9
|
81
|
|
Neuroendocrine neoplasms in the context of inherited tumor syndromes. a reappraisal focused on targeted therapies, file bb84411f-db79-4a53-9ab0-24c63b39ebe1
|
78
|
|
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family, file e3835325-4284-15e8-e053-a505fe0a3de9
|
77
|
|
Sunitinib treatment for advanced paraganglioma: case report of a novel SDHD gene mutation variant and systematic review of the literature, file e383532c-8efe-15e8-e053-a505fe0a3de9
|
72
|
|
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, file e3835322-4eb0-15e8-e053-a505fe0a3de9
|
68
|
|
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas, file e383531b-a8f7-15e8-e053-a505fe0a3de9
|
65
|
|
Endocrine dysfunction in patients with Fabry disease, file e3835322-3627-15e8-e053-a505fe0a3de9
|
65
|
|
Laryngeal neuroendocrine tumor with elevated serum calcitonin: a diagnostic and therapeutic challenge. Case report and review of literature, file e383532b-8c45-15e8-e053-a505fe0a3de9
|
65
|
|
Dopamine receptor expression and function in corticotroph ectopic tumors, file e3835326-90ac-15e8-e053-a505fe0a3de9
|
63
|
|
Vitamin D and cancer, file e3835321-f209-15e8-e053-a505fe0a3de9
|
60
|
|
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer, file e3835322-4bc4-15e8-e053-a505fe0a3de9
|
59
|
|
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs. A Multicenter Study, file e3835326-648b-15e8-e053-a505fe0a3de9
|
57
|
|
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors, file e3835326-81f7-15e8-e053-a505fe0a3de9
|
57
|
|
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review, file e383532b-e509-15e8-e053-a505fe0a3de9
|
57
|
|
Erectile Dysfunction Severity. The Role of Glycometabolic Compensation and Antihyperglycemic Drugs, file b7ca9deb-fdea-4c5d-994b-6f8b99fd4f34
|
56
|
|
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study, file e383531b-5f28-15e8-e053-a505fe0a3de9
|
56
|
|
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer, file e3835326-b48a-15e8-e053-a505fe0a3de9
|
54
|
|
Immune Checkpoint Inhibitors. New Weapons Against Medullary Thyroid Cancer?, file e383532c-62d9-15e8-e053-a505fe0a3de9
|
51
|
|
Bone metastases in neuroendocrine neoplasms: from pathogenesis to clinical management, file e3835326-b70c-15e8-e053-a505fe0a3de9
|
50
|
|
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms. Are we on the highway to hell?, file e3835328-6b87-15e8-e053-a505fe0a3de9
|
50
|
|
PRRT. identikit of the perfect patient, file e3835328-73ed-15e8-e053-a505fe0a3de9
|
50
|
|
Clinico-pathological features, treatments and survival of malignant insulinomas. a multicenter study, file e3835326-8912-15e8-e053-a505fe0a3de9
|
48
|
|
Emerging therapies in pheochromocytoma and paraganglioma. immune checkpoint inhibitors in the starting blocks, file e3835329-b6d3-15e8-e053-a505fe0a3de9
|
47
|
|
Diabetes and cancer, file e3835322-8304-15e8-e053-a505fe0a3de9
|
46
|
|
Diagnosis of Flier's syndrome in a patient with nondiabetic hypoglycemia. a case report and critical appraisal of the literature, file e383532e-c9dc-15e8-e053-a505fe0a3de9
|
45
|
|
Role of FGF System in Neuroendocrine Neoplasms. Potential Therapeutic Applications, file e383532c-0f79-15e8-e053-a505fe0a3de9
|
44
|
|
Advances in the Management of Medullary Thyroid Carcinoma. Focus on Peptide Receptor Radionuclide Therapy, file e3835328-5313-15e8-e053-a505fe0a3de9
|
42
|
|
Partitioning of bronchopulmonary carcinoids in two different prognostic categories by Ki-67 score, file e383532b-f84a-15e8-e053-a505fe0a3de9
|
42
|
|
Pathology reporting in neuroendocrine neoplasms of the digestive system: everything you always wanted to know but were too afraid to ask, file e383532c-4d20-15e8-e053-a505fe0a3de9
|
42
|
|
Sperm culture and bacterial susceptibility to antibiotics in a large andrological population: prevalence and impact on seminal parameters, file 8a1c4236-3bf3-4aac-b20b-7bad1e838a7d
|
40
|
|
Female sexual dysfunction in primary adrenal insufficiency, file e383532d-157b-15e8-e053-a505fe0a3de9
|
40
|
|
Commentary: case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management, file e383532d-a810-15e8-e053-a505fe0a3de9
|
40
|
|
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?, file e383532d-caef-15e8-e053-a505fe0a3de9
|
38
|
|
Nonconventional doses of somatostatin analogs in patients with progressing well-differentiated neuroendocrine tumor, file e3835329-666a-15e8-e053-a505fe0a3de9
|
34
|
|
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours, file 31437b5e-7df4-4192-8994-5f9d86ba8585
|
30
|
|
Early prediction of pancreatic cancer from new-onset diabetes. an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper, file dd4afa86-6544-422e-b6f3-bb451c1eb7b3
|
28
|
|
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma, file d506fb72-790f-4f1a-b839-ee5056f6ab87
|
25
|
|
Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure, file e3835326-8203-15e8-e053-a505fe0a3de9
|
23
|
|
Angiogenic factors as prognostic markers in neuroendocrine neoplasms, file e383532e-2fa1-15e8-e053-a505fe0a3de9
|
22
|
|
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy, file e383532e-c86d-15e8-e053-a505fe0a3de9
|
22
|
|
Erectile dysfunction as a marker of endocrine and glycemic disorders, file e383532e-612d-15e8-e053-a505fe0a3de9
|
21
|
|
Management of functional pancreatic neuroendocrine neoplasms, file 7a681ba3-e872-4d89-b6ab-2aca5e1a5c11
|
19
|
|
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour. One More Arrow in Our Quiver?, file e383532d-ef0f-15e8-e053-a505fe0a3de9
|
18
|
|
Prognostic significance of laterality in lung neuroendocrine tumors, file e383532e-d5ac-15e8-e053-a505fe0a3de9
|
18
|
|
Gestational Diabetes Mellitus pregnancy by pregnancy. early, late and nonrecurrent GDM, file c8a55a98-6969-4ff7-8778-c0fc2f96e990
|
17
|
|
Nuclear medicine and radiological imaging of pancreatic neuroendocrine neoplasms: a multidisciplinary update, file 04ef8c35-4228-4e85-a7ed-bcadb78d615c
|
16
|
|
Lipid metabolism and homeostasis in patients with neuroendocrine neoplasms: from risk factor to potential therapeutic target, file 5fa3d90e-612e-4172-aa24-20862b1fed1a
|
16
|
|
Immunotherapy of Neuroendocrine Neoplasms. Any Role for the Chimeric Antigen Receptor T Cells?, file 74e69ab8-db0a-46c1-8c3d-9175f720bc3b
|
16
|
| Totale |
14.639 |